Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intrathecal Pumps Market, by Application
1.4.2 North America Intrathecal Pumps Market, by Type
1.4.3 North America Intrathecal Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Intrathecal Pumps Market by Application
4.1 North America Pain Market by Region
4.2 North America Spasticity Market by Region
Chapter 5. North America Intrathecal Pumps Market by Type
5.1 North America Morphine Market by Country
5.2 North America Ziconotide Market by Country
5.3 North America Baclofen Market by Country
5.4 North America Bupivacaine Market by Country
5.5 North America Clonidine Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Intrathecal Pumps Market by Country
6.1 US Intrathecal Pumps Market
6.1.1 US Intrathecal Pumps Market by Application
6.1.2 US Intrathecal Pumps Market by Type
6.2 Canada Intrathecal Pumps Market
6.2.1 Canada Intrathecal Pumps Market by Application
6.2.2 Canada Intrathecal Pumps Market by Type
6.3 Mexico Intrathecal Pumps Market
6.3.1 Mexico Intrathecal Pumps Market by Application
6.3.2 Mexico Intrathecal Pumps Market by Type
6.4 Rest of North America Intrathecal Pumps Market
6.4.1 Rest of North America Intrathecal Pumps Market by Application
6.4.2 Rest of North America Intrathecal Pumps Market by Type
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Trails and Approvals:
7.1.6 SWOT Analysis
7.2 ICU Medical, Inc. (Smiths Medical)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teleflex, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Baxter International, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Tricumed Medizintechnik GmbH
7.7.1 Company Overview
7.8 Flowonix Medical, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Trails and Approvals:
7.9 DURECT Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 